BeStock  
Stocks › Biotechnology › SMMT

Summit Therapeutics SMMT

US equityMarket cap rank #716Biotechnology
$17.08 +$0.17 (+0.98%)
Market open · Oct 1, 11:50 am ET · After hours $16.92 +0.06%
Open$16.82
Prev close$16.91
Day range$16.59 – $17.18
Volume2.66M
Market cap$13.62B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts15
Average target$29.58+73.2% vs. price
  • Buy 67%
  • Hold 27%
  • Sell 7%
Low $9.80Now $17.08Avg $29.58High $43.00

Recent rating changes

The last 20 actions on file set price targets from $16.00 to $43.00, averaging $31.43.

DateFirmRatingTarget
1 Oct 2026 Barclays HOLD $20.00
30 Sep 2026 Citi BUY $43.00
30 Sep 2026 H.C. Wainwright HOLD –
29 Sep 2026 Piper Sandler HOLD $16.00
29 Sep 2026 Jefferies BUY –
29 Sep 2026 Evercore BUY $34.00
29 Sep 2026 Stifel BUY –
29 Sep 2026 Citi BUY $43.00
29 Sep 2026 H.C. Wainwright HOLD –
28 Sep 2026 Wells Fargo BUY $30.00
28 Sep 2026 UBS BUY $33.00
23 Sep 2026 H.C. Wainwright HOLD –
21 Sep 2026 Barclays HOLD $18.00
13 Sep 2026 UBS BUY $33.00
13 Sep 2026 Citi BUY $40.00
13 Sep 2026 Goldman Sachs BUY $41.00
9 Sep 2026 Jefferies BUY $25.00
8 Sep 2026 UBS BUY $33.00
3 Sep 2026 Clear Street BUY $31.00
3 Sep 2026 H.C. Wainwright HOLD –

Discussion

No comments yet — be the first to weigh in on SMMT.

Leave a comment

Scroll to Top